Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- IBB.MX
- Price
- 3037.75
- Stock movement up
- +3.75 (0.12%)
- Company name
- iShares Trust - iShares Biotechnology ETF
- Exchange
- (MX ,
- Currency
- MXN )
- Market cap
- -
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 4.68%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-11-21
DIVIDENDS
IBB.MX does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3026.00 |
| Daily high | 3037.75 |
| Daily low | 3026.00 |
| Daily Volume | 0K |
| All-time high | 333332.99 |
| 1y analyst estimate | - |
| Beta | - |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | 15 Sep 2025 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| IBB.MX | S&P500 | |
| Current price drop from All-time high | -99.09% | -5.07% |
| Highest price drop | -99.31% | -19.00% |
| Date of highest drop | 22 Apr 2025 | 8 Apr 2025 |
| Avg drop from high | -99.20% | -2.73% |
| Avg time to new high | - | 6 days |
| Max time to new high | 281 days | 89 days |
COMPANY DETAILS
Marketcap
-
Marketcap category
Description
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Employees
Investor relations
-
SEC filings
CEO
Country
Mexico
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Biotech strength is back, with IBB, PBE, FBT, CANC and HELX climbing as cheaper valuations, rate-cut hopes, FDA approvals and strong deal activity fuel biotech gains.
November 21, 2025
Recent market turmoil led by an artificial-intelligence selloff seems like the perfect opportunity for lagging, less risky areas of the market to shine. Not all seem up to the task.
November 18, 2025
Dr. Richard Pazdur is “likely the best possible person for the role,” says one analyst. A calmer course for the FDA could add fuel to the recent run-up in biotech stocks.
November 12, 2025
We recently published Trending Analyst Calls: 10 Stocks to Buy and Sell. Biotechnology ETF (NASDAQ:IBB) is one of the trending analyst calls. Jason Snipe, Founder and CIO of Odyssey Capital Advisors, ...
October 30, 2025
Barron’s called Holz to ask about what’s happened to the biotech sector since our healthcare roundtable.
October 17, 2025
Gilead looks attractive again. Its innovative edge and new crop of medications are performing well across multiple specialties.
October 2, 2025
Vivek Ramaswamy sold more than $22 million worth of Roivant Sciences stock in three separate transactions last week, according to a filing with the U.S. Securities and Exchange Commission. Ramaswam...
September 14, 2025
Smart Beta ETF report for IBB
August 18, 2025
Next page